TTRX Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: April 07, 2026
Report Source: 2025 Annual Report
Turn Therapeutics Inc. Stock Analysis TTRX
Turn Therapeutics, Inc. is a pharmaceutical and medical device development company. The company is headquartered in Westlake Village, California. The company went IPO on 2025-10-08. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble active pharmaceutical ingredients (APIs) in oil-based carriers without the use of emulsifiers. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis. Its products and programs include GX-03/Hexagen for Wounds (Hexagen (K160872)), GX-03/Hexagen for Derm (AtopX (K171191)), Sterile Gauze Impregnated with GX-03/Hexagen (XEAL (K183681)), Sterile Collagen/Hexagen Powder (FleX Product), GX-03/Hexagen for Moderate-Severe Eczema, and GX-03/Hexagen for Onychomycosis. GX-03/Hexagen for Wounds (Hexagen (K160872)) is a medical device for treating wounds and burns. GX-03/Hexagen for Derm (AtopX (K171191)) is a medical device for managing dermatitis.
Read More Turn Therapeutics Inc (TTRX) Chart
Key Statistics of Turn Therapeutics Inc (TTRX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$3.90Volume
29.43KP/E Ratio (TTM)
-52 Week Range
Market Cap
110.22MAvg. Volume
22.27KDividend Yield
-Financial Metrics & Statements of Turn Therapeutics Inc (TTRX)
FAQ's for Turn Therapeutics Inc (TTRX)
- According to Musaffa’s Shariah screening methodology, Turn Therapeutics Inc (TTRX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.